. . . . . . . "[A phase 2, open-label, dose-ranging study was conducted in IFN-alfa-na�ve patients with genotype 1 chronic hepatitis C to evaluate the antiviral activity, safety, and pharmacokinetics of alb-IFN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:36+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .